Abstract
Background: To understand the molecular and morphological alterations in the tight junction in colorectal cancer (CRC) tissues, the expression of eight tight junction proteins in normal and cancer colorectal tissues were compared. Patients and Methods: Adenocarcinoma tissues and paired normal mucosa were resected from surgical specimens of CRC patients. The expression of occludin, ZO-1, ZO-2, and claudin-1 ~ 5 was analyzed at the mRNA level by quantitative reverse transcription-polymerase chain reaction (RT-PCR) and at the protein level by immunohistochemistry. Results: The expression of claudin-1 and claudin-2 in cancer tissues was up-regulated 40- and 49.2-fold, respectively, at the mRNA level, as compared with that in normal tissues. The up-regulation of these two claudins was also observed at the protein level and it appeared to depend on the depth of tumor invasion. Conclusion: Claudin-1 and claudin-2 were found to be overexpressed in CRC tissues. They may be useful as tumor markers and targets for the treatment of colorectal cancer.
Footnotes
- Received April 23, 2007.
- Revision received July 25, 2007.
- Accepted August 1, 2007.
- Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
In this issue
Jump to section
Related Articles
Cited By...
- Molecular Signatures for Microbe-Associated Colorectal Cancers
- Chitinase 3-like 1, Carcinoembryonic Antigen-related Cell Adhesion Molecule 6, and Ectopic Claudin-2 in the Carcinogenic Processes of Ulcerative Colitis
- Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis
- Polymorphisms in CLDN1 are associated with age and differentiation of triple-negative breast cancer patients
- Tight junction proteins in gastrointestinal and liver disease
- Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs
- Afadin cooperates with Claudin-2 to promote breast cancer metastasis
- Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells
- Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells
- Expression of Claudins in Human Clear Cell Renal Cell Carcinoma
- Low Expression of Claudin-1 and Presence of Poorly-differentiated Tumor Clusters Correlate with Poor Prognosis in Colorectal Cancer
- Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes
- Increased Claudin-1 Protein Expression in Hepatic Metastatic Lesions of Colorectal Cancer
- Decreased Expression of Claudin-1 in Rectal Cancer: A Factor for Recurrence and Poor Prognosis
- Increased Claudin-1 Protein Expression Contributes to Tumorigenesis in Ulcerative Colitis-associated Colorectal Cancer
- Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
- Claudin-1 Protein is a Major Factor Involved in the Tumorigenesis of Colorectal Cancer
- Claudin-1 Protein Expression is a Prognostic Marker of Patient Survival in Renal Cell Carcinomas
- Defective Claudin-7 Regulation by Tcf-4 and Sox-9 Disrupts the Polarity and Increases the Tumorigenicity of Colorectal Cancer Cells